Cardio3 BioSciences Receives Its Accreditation Number From The Belgian Federal Agency For Medicines And Health Products For The Manufacture Of C-Cure(TM) For Human Use

Mont-Saint-Guibert – Belgium, November 18, 2008 - Cardio3 BioSciences, announces that it has received its Good Manufacturing Practices (GMP) accreditation number for the manufacture of clinical batches of C-Cure, the only advanced therapy medicinal product of its kind.